4//SEC Filing
Slootweg Hugo Alexander 4
Accession 0001104659-18-047460
CIK 0001737953other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 5:26 PM ET
Size
25.4 KB
Accession
0001104659-18-047460
Insider Transaction Report
Form 4
Slootweg Hugo Alexander
Director10% Owner
Transactions
- Conversion
Warrant (right to buy)
2018-07-24+248,672→ 248,672 total(indirect: See Footnote)→ Common Stock (248,672 underlying) - Conversion
Common Stock
2018-07-24+994,688→ 994,688 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-24+2,579,881→ 3,574,569 total(indirect: See Footnote) - Conversion
Warrant (right to buy)
2018-07-24−248,672→ 0 total(indirect: See Footnote)→ Series Seed Convertible Preferred Stock (248,672 underlying) - Conversion
Series Seed Convertible Preferred Stock
2018-07-24−994,688→ 0 total(indirect: See Footnote)→ Common Stock (994,688 underlying) - Conversion
Series A Convertible Preferred Stock
2018-07-24−2,579,881→ 0 total(indirect: See Footnote)→ Common Stock (2,579,881 underlying) - Conversion
Common Stock
2018-07-24+1,013,547→ 4,588,116 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-24$15.00/sh+133,333$1,999,995→ 4,721,449 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2018-07-24−1,013,547→ 0 total(indirect: See Footnote)→ Common Stock (1,013,547 underlying) - Award
Stock Option (right to buy)
2018-07-24+13,500→ 13,500 totalExercise: $15.00Exp: 2028-07-19→ Common Stock (13,500 underlying)
Footnotes (5)
- [F1]In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the "Preferred Stock") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date.
- [F2]The securities are held directly by Forbion Capital Fund III Cooperatief U.A ("Forbion Coop"). Forbion III Management B.V. ("Forbion Management") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any.
- [F3]Reflects warrants to acquire shares of the Issuer's Series Seed Convertible Preferred Stock which automatically converted into warrants to acquire shares of the Issuer's common stock immediately prior to the completion of the Issuer's initial public offering on a 1-for-9.94688 basis without payment or consideration. The warrants have no expiration date. The exercise price is $1.01 per share of the issuer's common stock.
- [F4]Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis.
- [F5]This option was granted on July 19, 2018 subject to the completion of the Issuer's initial public offering, which closed on July 24, 2018. 25% of the shares underlying this stock option vest on July 19, 2019 and the remainder of the shares underlying this stock option vest in 24 equal monthly installments thereafter.
Documents
Issuer
Replimune Group, Inc.
CIK 0001737953
Entity typeother
Related Parties
1- filerCIK 0001744922
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 5:26 PM ET
- Size
- 25.4 KB